Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2025-12-28 @ 10:50 PM
Study NCT ID:
NCT04129151
Status:
TERMINATED
Last Update Posted:
2024-08-01
First Post:
2019-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Palbociclib + Ganitumab In Ewing Sarcoma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-14
First Submit QC Date:
None
Study First Post Date:
2019-10-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-24
Results First Submit QC Date:
None
Results First Post Date:
2024-07-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-31
Last Update Post Date:
2024-08-01
Last Update Post Date Type:
ACTUAL